| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 781757 | 03261001 | EMTRIVA 200 MG CAPSULAS | EMTRIVA 200 MG CAPSULAS, 30 cápsulas | 200 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03261001/03261001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03261001/03261001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16632 | GILEAD SCIENCES S.L. | 2003-12-02 | 1 | 1 | 1 | 2003-12-02 | 2003-12-02 | 0 | 2011-08-31 | View Edit Delete | ||||||||||||
| 781179 | 03261003 | EMTRIVA 10 MG/ML SOLUCION ORAL | EMTRIVA 10 MG/ML SOLUCION ORAL, 1 frasco de 170 ml | 10 mg/ml | 6 | 170 | 26 | 1 frasco de 170 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03261003/03261003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03261003/03261003_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16632 | GILEAD SCIENCES S.L. | 2003-12-02 | 1 | 1 | 1 | 2003-12-02 | 2003-12-02 | 1 | 2011-08-31 | View Edit Delete | ||||||||||||
| 784140 | 03262006 | EMEND 125 MG CAPSULAS DURAS/EMEND 80 MG CAPSULAS DURAS | EMEND 125 MG CAPSULAS DURAS/EMEND 80 MG CAPSULAS DURAS, (125 mg) 1 cáps + (80 mg) 2 cáps | 80 mg + 125 mg | 5 | 3 | 43 | (125 mg) 1 cáps + (80 mg) 2 cáps | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03262006/03262006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03262006/03262006_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2003-12-02 | 1 | 1 | 1 | 2003-12-02 | 2003-12-02 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 700697 | 03263002 | DUKORAL SUSPENSION Y GRANULADO EFERVESCENTE PARA SUSPENSION ORAL | DUKORAL SUSPENSION Y GRANULADO EFERVESCENTE PARA SUSPENSION ORAL, 1 vial bebible de 3 ml + 1 sobre, 2 x 1 dosis | N/A (vacuna) | 45 | 1 | 17 | 1 vial bebible de 3 ml + 1 sobre, 2 x 1 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03263002/03263002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03263002/03263002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19693 | VALNEVA SWEDEN AB | 2004-10-01 | 1 | 1 | 1 | 2004-10-01 | 2018-03-14 | 1 | 2012-01-02 | 650139, 653420, 656761 | View Edit Delete | |||||||||||
| 813014 | 03264001 | ZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSION | ZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSION, 1 equipo para preparación radiofarmacéutica | 1,6 mg/ml | 45 | 1 | 70 | 1 equipo para preparación radiofarmacéutica | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03264001/03264001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03264001/03264001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34099 | SPECTRUM PHARMACEUTICALS B.V. | 2004-02-18 | 1 | 1 | 1 | 2004-02-18 | 2004-02-18 | 1 | 2011-10-10 | View Edit Delete | ||||||||||||
| 653346 | 03265003 | BONVIVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BONVIVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 1 comprimido | 150 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03265003/03265003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03265003/03265003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35106 | LABORATORIOS RUBIO S.A. | 2005-10-03 | 1 | 1 | 1 | 2005-10-03 | 2011-11-22 | 1 | 2012-01-02 | 651556 | View Edit Delete | |||||||||||
| 728985 | 03265003IP | BONVIVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | BONVIVA 150 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 1 comprimido | 150 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03265003IP/03265003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03265003IP/03265003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35106 | ELAM PHARMA LABS S.L. | 2020-07-24 | 1 | 1 | 1 | 2020-07-25 | 2020-07-24 | 1 | 2023-01-16 | View Edit Delete | ||||||||||||
| 660113 | 03268004 | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 180 comprimidos | 625 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03268004/03268004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03268004/03268004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2008-03-25 | 1 | 1 | 1 | 2008-03-25 | 2008-03-25 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 827394 | 03269001 | FASLODEX 250 mg/5 ml SOLUCION INYECTABLE | FASLODEX 250 mg/5 ml SOLUCION INYECTABLE, 1 jeringa precargada de 5 ml | 250 mg | 33 | 1 | 61 | 1 jeringa precargada de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03269001/03269001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03269001/03269001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34774 | ASTRAZENECA FARMACEUTICA SPAIN S.A. | 2004-04-19 | 1 | 1 | 1 | 2004-04-19 | 2004-04-19 | 1 | 2011-11-16 | View Edit Delete | ||||||||||||
| 700642 | 03270001 | KENTERA 3,9 mg/24 HORAS, PARCHE TRANSDERMICO | KENTERA 3,9 mg/24 HORAS, PARCHE TRANSDERMICO, 8 parches | 3,9 mg/24 h | 74 | 8 | 28 | 8 parches | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03270001/03270001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03270001/03270001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | LABORATORIOS GEBRO PHARMA S.A. | 2004-08-13 | 1 | 1 | 1 | 2004-08-13 | 2015-12-15 | 0 | 2014-05-29 | 827345 | View Edit Delete | |||||||||||
| 760629 | 04273001 | LYSODREN 500 mg COMPRIMIDOS | LYSODREN 500 mg COMPRIMIDOS, 100 comprimidos | 500 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04273001/04273001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04273001/04273001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 2004-08-02 | 1 | 1 | 1 | 2004-08-02 | 2004-08-02 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 820910 | 04274001 | VELCADE 3,5 mg, POLVO PARA SOLUCION INYECTABLE | VELCADE 3,5 mg, POLVO PARA SOLUCION INYECTABLE, 1 vial | 3,5 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04274001/04274001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04274001/04274001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6153 | JANSSEN CILAG S.A. | 2004-05-13 | 1 | 1 | 1 | 2004-05-13 | 2004-05-13 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 658425 | 04275001 | LITAK 2 mg/ml SOLUCION INYECTABLE | LITAK 2 mg/ml SOLUCION INYECTABLE, 1 vial de 5 ml | 2 mg/ml inyectable 5 ml | 1 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04275001/04275001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04275001/04275001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12526 | KERN PHARMA S.L. | 2007-07-27 | 1 | 1 | 1 | 2007-07-27 | 2007-07-27 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 658426 | 04275002 | LITAK 2 mg/ml SOLUCION INYECTABLE | LITAK 2 mg/ml SOLUCION INYECTABLE, 5 viales de 5 ml | 2 mg/ml inyectable 5 ml | 1 | 5 | 34 | 5 viales de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04275002/04275002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04275002/04275002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12526 | KERN PHARMA S.L. | 2007-07-27 | 1 | 1 | 1 | 2007-07-27 | 2007-07-27 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 728154 | 04276002 | ABILIFY 5 MG COMPRIMIDOS | ABILIFY 5 MG COMPRIMIDOS 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276002/04276002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276002/04276002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2004-06-24 | 1 | 1 | 1 | 2004-06-24 | 2004-06-24 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 728196 | 04276007 | ABILIFY 10 MG COMPRIMIDOS | ABILIFY 10 MG COMPRIMIDOS, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276007/04276007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276007/04276007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2004-06-24 | 1 | 1 | 1 | 2004-06-24 | 2004-06-24 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 720799 | 04276007IP | ABILIFY 10 MG COMPRIMIDOS | ABILIFY 10 MG COMPRIMIDOS, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276007IP/04276007IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276007IP/04276007IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15183 | DIFARMED S.L. | 2018-02-20 | 1 | 1 | 1 | 2018-02-21 | 2018-02-20 | 1 | 2018-06-06 | View Edit Delete | ||||||||||||
| 723945 | 04276007IP1 | ABILIFY 10 MG COMPRIMIDOS | ABILIFY 10 MG COMPRIMIDOS, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276007IP1/04276007IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276007IP1/04276007IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | MELYFARMA S.L. | 2018-10-31 | 1 | 1 | 1 | 2018-11-01 | 2018-10-31 | 1 | 2018-12-10 | View Edit Delete | ||||||||||||
| 724618 | 04276007IP2 | ABILIFY 10 MG COMPRIMIDOS | ABILIFY 10 mg COMPRIMIDOS, 28 comprimidos | 10 | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276007IP2/04276007IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276007IP2/04276007IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | ELAM PHARMA LABS S.L. | 2019-01-22 | 1 | 1 | 1 | 2019-01-23 | 2019-01-22 | 1 | 2019-09-09 | View Edit Delete | ||||||||||||
| 727740 | 04276007IP3 | ABILIFY 10 MG COMPRIMIDOS | ABILIFY 10 MG COMPRIMIDOS, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04276007IP3/04276007IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04276007IP3/04276007IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | ECOFAR PRODUCTOS S.L. | 2020-01-14 | 1 | 1 | 1 | 2020-01-15 | 2020-01-14 | 1 | 2020-05-07 | View Edit Delete |
Page 12 of 1036, showing 20 records out of 20709 total, starting on record 221, ending on 240